AUG 17, 2026 · JOURNAL ARTICLE
Thirty years of NCI thyroid cancer research investment (1996–2025): a longitudinal portfolio analysis of funding trends, molecular target emphasis and thematic evolution
Frontiers in Oncology
This is a descriptive portfolio analysis of research funding trends using administrative data; it characterizes what has been funded rather than testing clinical or scientific hypotheses, and generates no outcome data or efficacy evidence.
Reported
Cumulative NCI fundingUSD 343.8 million (BRDPI-adjusted 2025 doll…
Peak annual funding year2015
Peak annual award-years53